• Home
  • A Phase I, Double-blind, Randomized, Placebo-controlled, Single Dose-escalation Study to Evaluate the Tolerability, and Safety of Cytisinicline in Adult Smokers.

A Phase I, Double-blind, Randomized, Placebo-controlled, Single Dose-escalation Study to Evaluate the Tolerability, and Safety of Cytisinicline in Adult Smokers.

Author List
Jacobs C, Fonseca M, Rigotti NA, Benowitz N, Clarke A, Cain D
Publication
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Publication ID (Profile URL)
https://researcherprofiles.org/profile/366106293
Publication Year
2023
PubMed ID
36198104
Publication Title
Jacobs C, Fonseca M, Rigotti NA, Benowitz N, Clarke A, Cain D. A Phase I, Double-blind, Randomized, Placebo-controlled, Single Dose-escalation Study to Evaluate the Tolerability, and Safety of Cytisinicline in Adult Smokers. Nicotine Tob Res. 2023 03 22; 25(4):814-820.